Finding the positives....., page-3

Company has on multiple occasions stated that they do not intend to progress these products beyond Ph2 Trials.


The bolded part of that statement is flawed as the company on multiple occasions has also said they would license out at least one of the DEP drugs prior to the completion of the phase 2 in house trials (amongst a host of other promises they touted that never materialised) .... see how that works ?


Granted Cheryl is now at the helm so we can put behind us all of what the previous CEO said that never came to fruition, but Cheryl has also touted all of these so called 'potentials' in her recent letter to shareholders so if there is no follow through on them, then sadly we will be right back where we started ?


I also disagree with you on Viraleze as a viable product having used it for the last 3 years - I hope it remains in the long run as COVID-19 still affects people, especially in the over 45 yo demographic


https://www.health.gov.au/topics/covid-19/reporting#covid19-associated-deaths

COVID-19 reporting

This page provides update on national COVID-19 spread, vaccination and treatment metrics.




https://covid.cdc.gov/covid-data-tracker/#maps_deaths-3-months

_{United States COVID-19 Hospitalizations, Deaths, Emergency Department (ED) Visits, and Test Positivity by Geographic Area}